Delivery Order SPE2DB22D2211-SPE2DB25FRVPE

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Levocetirizine 2.5 mg/5 ml solution in 148 ml bottles, with a ceiling value of $2,771.76 and a period of performance through May 1, 2025. The contract is not set aside and was awarded on April 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,503.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,869,058 units of LEVOCETIRIZINE 2.5 MG/5 ML SOL 148ML, a pharmaceutical product. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,202.44, is for the delivery of 4564840964 - Levocetirizine 5 mg Tablets in 90-count packages. The award is a firm fixed-price delivery order with a completion date of June 10, 2024. Amerisourcebergen is a major pharmaceutical distribution company that has been awarded several federal contracts to supply a wide range of medications and...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,661.98, is for the delivery of 100 tablets of the medication Cetirizine HCL 5 mg. The contract has an ultimate completion date of July 1, 2025. Amerisourcebergen Drug Corp is a for-profit corporate entity registered in the System for Award Management (SAM) and has a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, for the delivery of Cetirizine HCL 1 mg/ml solution in 120 ml bottles. The award, valued at $7,769.01, is a firm fixed-price delivery order with a completion date of May 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Cetirizine HCL 5 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,168.23, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of January 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,127.36 firm-fixed-price delivery order is for the supply of CETIRIZINE-PSE ER 5-120 MG TAB 12S, a type of pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,202.06 firm fixed-price delivery order is for the supply of CETIRIZINE-PSE ER 5-120 MG TAB 24S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cetirizine HCL 5 mg tablets in 100-count bottles, with a total ceiling value of $2,649.94 and a performance period through May 12, 2025. The contract is not set-aside and was awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,645.49 firm fixed price contract is for the delivery of 4,564,631,216 milliliters of Cetirizine HCl 1 mg/ml solution in 120 ml bottles. The award has a completion date of May 17, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRVPE
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,476.63, is for the delivery of Levocetirizine 2.5 mg/5 ml solution in 148 ml bottles. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in SAM.gov since 2002 and serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, providing a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This delivery order contract is not designated as a set-aside.

Generated 7/18/25, 9:53 AM